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Abstract
Background Some authors have proposed different predictive factors of severe acute cholecystitis, but generally, the
results of risk analyses are expressed as odds ratios, which makes it difficult to apply in the clinical practice of the
acute care surgeon. The severe form of acute cholecystitis should include both gangrenous and phlegmonous
cholecystitis, due to their severe clinical course, and cholecystectomy should not be delayed. The aim of this study
was to create a nomogram to obtain a graphical tool to compute the probability of having a severe acute
cholecystitis.
Methods This is a retrospective study on 393 patients who underwent emergency cholecystectomy between January
2010 and December 2015 at the Acute Care Surgery Service of the S. Anna University Hospital of Ferrara, Italy.
Patients were classified as having a non-severe acute cholecystitis or a severe acute cholecystitis (i.e., gangrenous
and phlegmonous) based on the final pathology report. The baseline characteristics, pre-operative signs, and abdom-
inal ultrasound (US) findings were assessed with a stepwise multivariate logistic regression analysis to predict the
risk of severe acute cholecystitis, and a nomogram was created.
Results Age as a continuous variable, WBC count ≥ 12.4 × 103/μl, CRP ≥9.9 mg/dl, and presence of US thickening
of the gallbladder wall were significantly associated with severe acute cholecystitis at final pathology report. A
significant interaction between the effect of age and CRP was found. Four risk classes were identified based on the
nomogram total points.
Conclusions Patients with a nomogram total point ≥ 74 should be considered at high risk of severe acute cholecystitis (at 74 total
point, sensitivity = 78.5%; specificity = 78.2%; accuracy = 78.3%) and this finding could be useful for surgical planning once
confirmed in a prospective study comparing the risk score stratification and clinical outcomes.
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Introduction
Do I need to operate on that in the middle of the night? Any
acute care surgeon must answer this question based on the
evaluation of the disease process severity and the need to
schedule the operation according to the priority of surgical
patients visited in the emergency department. The triage is
an important process on focusing the resources and to guaran-
tee the proper timing for the treatment. In the emergency de-
partment, acute cholecystitis represents an indication for early
cholecystectomy within 72 h after the onset of symptoms;1,2
however, the presence of a severe acute cholecystitis may
increase the risk of morbidity and mortality and may impose
a surgical prioritization in these patients compared to others.
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Of note, it has been suggested that the severe form of acute
cholecystitis should include both gangrenous and
phlegmonous cholecystitis.3 Usually, acute cholecystitis be-
gins with an attack of biliary colic, often in a patient who
has had previous attacks, yet the pain persists and localizes
in the right upper quadrant.4 Fever and an elevation of the
white blood cell (WBC) count are classically described in
patients with acute cholecystitis, but either or both may be
absent.5 The C-reactive protein (CRP) level is frequently
elevated.6 The abdominal ultrasound (US) is the most com-
mon imaging study used in diagnosis, and it is usually the first
instrumental test because of its ready availability.4 The accu-
rate clinical diagnosis of acute inflammation of the gallbladder
may often be difficult due to the similarity of symptoms be-
tween an attack of biliary colic and acute cholecystitis.7 Yokoe
et al. have proposed and appraised the diagnostic criteria for
acute cholecystitis, but there are some limitations of these
criteria. In fact, they have not defined the cutoff of the WBC
count and CRP level that can be used for the diagnosis of
severe acute cholecystitis, and they have not described factors
for the discrimination of non-severe and severe acute
cholecystitis.8 Some authors have proposed different predic-
tive factors of severe acute cholecystitis, but generally, the
results of risk analyses are expressed as odds ratios (ORs),
which makes it difficult to apply in the clinical practice of
the acute care surgeon.3,7,9–15
The aim of this study was to identify predictors for
assessing the risk of severe acute cholecystitis (i.e., gangre-
nous and phlegmonous) and, on the basis of the estimated
model, to create a nomogram for obtaining a graphical tool
to compute the probability of having a severe acute
cholecystitis.
Materials and Methods
Study Population and Data Collection
This is a retrospective cohort study on patients operated be-
tween January 2010 and December 2015 at the Acute Care
Surgery Service of the S. Anna University Hospital of Ferrara,
Italy. This study was conducted in accordance with the guide-
lines described in the statement on strengthening the reporting
of observational studies in epidemiology (STROBE).16
Patients admitted either through the emergency department
or with consultation on the medical service who underwent
an emergency cholecystectomy were identified retrospective-
ly from the hospital electronic medical records in which the
data were included prospectively. A retrospective analysis was
obtained from a database in which patients’ data were collect-
ed with details of gender, age, diabetes, pre-operative local
signs of inflammation (right upper quadrant mass/pain/tender-
ness, Murphy’s sign), pre-operative systemic signs of
inflammation (temperature, WBC count, neutrophils count,
CRP level), pre-operative abdominal US findings (thickening
of the gallbladder wall, pericholecystic fluid, gallbladder en-
largement, gallbladder stones), and final pathology report that
it is the gold standard for diagnosis of acute cholecystitis.4
Due to the aim of this study, the exclusion criterion was the
absence in the electronic medical records of at least one data
reported above. The abdominal US is the first-line test due to
the superiority of this exam in establishing the diagnosis of
acute cholecystitis compared to the computed tomography
(CT),17 and only in some patients a CT was performed to
evaluate complications of acute cholecystitis. Thus, for the
creation of a nomogram, CT findings were excluded.
Surgical specimens were examined at the time of surgery
by seven pathologists and, because of the aim of the study,
final pathology reports were reviewed and classified accord-
ing to the pathological criteria reported in a previous study in
which the predictive factors of severe acute cholecystitis were
evaluated.3 Therefore, patients were classified as having a
non-severe acute cholecystitis (i.e., acute and chronic chole-
cystitis with neutrophilic and/or lymphoplasma cellular infil-
tration of the gallbladder wall) or a severe acute cholecystitis
(i.e., gangrenous cholecystitis when a transmural necrosis of
the gallbladder wall was present, and phlegmonous cholecys-
titis when a necrosis that involved a limited part of the layers
of the wall was identified) according to the final pathology
report.
This study was approved by the Institutional Review Board
at the S. Anna University Hospital of Ferrara (Ethical
Committee for Human Subject Research study number:
170185). All patients signed a written informed consent.
Data collection and analysis were performed in compliance
with the Helsinki Declaration of 1975.
Statistical Analysis
The statistical analysis was performed on 393 out of 516 pa-
tients who underwent an emergency cholecystectomy. We
randomly split the study population (393 patients) into two
groups: one for model derivation (75% of the population—
295 patients) and the other for model validation (the remain-
ing 25%—98 patients). No imputation methods were used in
analysis. Data are presented as frequencies with percentages,
and medians with 25–75th percentiles (interquartile range—
IQR 25–75) depending on the type of data and their distribu-
tion. The Shapiro-Wilk test was used to assess the assumption
of normality. Differences between proportions from the deri-
vation and validation cohorts were calculated using χ2 test,
and Mann–Whitney U test was used to compare skewed data.
A receiver operating characteristic (ROC) curve was used: (1)
to investigate the diagnostic accuracy ofWBC count and CRP
level in predicting the severe acute cholecystitis and (2) to
identify the optimal cutoff point of these tests to discriminate
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patients with disease from those without disease. The best
cutoff was defined as the titer generating the highest
Youden’s J statistic, which combines information about sensi-
tivity and specificity into a single value. The model was de-
veloped using data solely from a derivation cohort, which
included 295 patients. Variables were evaluated by univariate
logistic regression analysis, while the model was developed
using a stepwise multivariate logistic regression analysis.
Variables were selected on the basis of their associations with
increased severe acute cholecystitis risk (p < 0.05; univariate
analysis) or known relevance, and they were included in the
variable pool for a stepwise regression model. The risk score
was calculated using regression coefficients from the final
multivariate model. Once a final model was defined, patients
were divided into four risk groups according to low, interme-
diate, high, and very high risk of severe acute cholecystitis.
We then used the Cochran-Armitage trending statistic, which
modifies the χ2 test to incorporate a suspected ordering, to
assess the ability of the risk score system to differentiate low-
risk from high-risk patients in a graded response.
Model Performance Assessment
To evaluate the performance model, we considered overall
performance, calibration, and discrimination. We used the le
Cessie-van Houwelingen-Copas test18,19 to evaluate the over-
all goodness of fit. The le Cessie-van Houwelingen-Copas test
uses the sum of squared differences of the individual observed
and the predicted risks. We assessed model calibration using
the calibration graph. BNon-parametric^ is a smoothed func-
tion of observed events plotted versus predicted probabilities,
while BIdeal^ is the ideal 45-degree line and the triangles in-
dicate the outcomes for deciles of prediction with their 95%
confidence intervals.20,21 We assessed model discrimination
using the concordance (c) statistic which represents the area
under the ROC curve (larger values indicate improved dis-
crimination) and defines how well a model or prediction rule
can discriminate between patients who do and do not have an
event and measures how well a clinical prediction rule cor-
rectly ranks patients in order by risk.20 Using the R Brms^
package,22,23 we obtained a convenient graphical tool (i.e.,
nomogram) to compute the probability of having a severe
acute cholecystitis. Each predictor variable has a correspond-
ing point value based on its position on the top point scale and
contribution to the model. A total score is given to each sub-
ject by adding up the points. The probability of developing a
severe cholecystitis for each subject can be calculated by the
total score from the scale presented on the bottom line.
The performance of the algorithm obtained from the deri-
vation cohort was tested on the randomly selected validation
cohort (98 patients). In the validation study, conditions, defi-
nitions, and measurements were identical to those of the de-
velopment study.
Significance was considered for values of p < 0.05.
Statistical analysis was performed with IBM SPSS Statistics
for Windows, Version 24.0 (IBM Corp. Armonk, NY: IBM




A total of 516 emergency cholecystectomies were performed
between January 2010 and December 2015 at the Acute Care
Surgery Service. Among these 516 patients, in 94 (18.2%)
patients, CRP evaluation was not carried out in the emergency
department or in the medical service, and in 29 (5.6%) pa-
tients, abdominal USwas not done because the first evaluation
was the abdominal CT scan. Thus, these patients were exclud-
ed from the study. Three hundred and ninety-three patients
were enrolled for this study and the baseline characteristics
of patients in the derivation and the validation cohorts are
shown in Table 1. There are no differences in the baseline
characteristics between the two groups; however, there is a
significantly lower percentage of patients with severe acute
cholecystitis in the validation cohort compared to the deriva-
tion cohort (28.6 vs. 39.3%, respectively; p = 0.026).
Table 2 shows the baseline characteristics, pre-operative
signs, and pre-operative imaging findings of patients in the
derivation cohort according to the final pathology report.
Male gender and diabetes prevail in the group of severe acute
cholecystitis. Patients with severe acute cholecystitis were
older, with a higher WBC count and CRP level, and they
had more frequently US thickening of the gallbladder wall
and US pericholecystic fluid collection. No differences were
found in terms of local signs of inflammation between the two
groups.
Predictive Factors of Severe Acute Cholecystitis
and Nomogram Development
Figure 1 shows the ROC curves in the derivation cohort for
both WBC count and CRP level as a single predictor of severe
acute cholecystitis. The area under the curve (AUC) for WBC
count as the single predictor has been calculated as being
0.782, with a 95% CI of 0.730–0.835; and the ROC curve
analysis found the optimal cutoff of WBC count to be
12.4 × 103/μl, to discriminate patients with disease from those
without disease. The AUC for CRP level as the single predic-
tor has been calculated as being 0.780, with a 95% CI of
0.724–0.835; and the best cutoff of CRP was 9.9 mg/dl.
The univariate logistic regression analysis performed in the
derivation cohort showed that male gender, age as a continu-
ous variable, presence of diabetes, temperature ≥ 38 °C, WBC
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count ≥ 12.4 × 103/μl, CRP level ≥ 9.9 mg/dl, US thickening
of the gallbladder wall, and US pericholecystic fluid were
significantly associated to severe acute cholecystitis (Table 3).
The multivariate approach has been developed through a
stepwise multivariate logistic regression analysis. Results
showed that WBC count ≥ 12.4 × 103/μl (OR 5.559; 95%
Table 1 Baseline characteristics and final pathology report of patients in the derivation and the validation cohorts
Derivation cohort (N = 295) Validation cohort (N = 98) p
Gender [N (%)] 0.641
Male 141 (47.8) 50 (51.0)
Female 154 (52.2) 48 (49.0)
Age (years) 68 (52–78) 67 (52–77) 0.851
Diabetes [N (%)] 41 (13.9) 13 (13.3) 1.000
Temperature ≥ 38 °C [N (%)] 32 (10.8) 11 (11.2) 1.000
Pre-operative total WBC count (×103/μl) 11.3 (8.2–14.8) 11.3 (8.2–15.2) 0.868
Pre-operative neutrophils count (×103/μl) 8.9 (5.8–12.2) 8.4 (5.1–12.6) 0.470
Pre-operative CRP level (mg/dl) 3.0 (0.7–13.9) 3.4 (0.6–11.2) 0.524
Pre-operative abdominal ultrasound [N (%)] 295 (100) 98 (100) –
Final pathology report [N (%)] 0.026
Chronic cholecystitis 117 (39.7) 37 (37.8)
Acute cholecystitis 62 (21.0) 33 (33.7)
Severe Acute cholecystitis 116 (39.3) 28 (28.6)
WBC white blood cell, CRP C-reactive protein
Table 2 Baseline characteristics,
pre-operative signs, and pre-
operative imaging findings of
patients in the derivation cohort
according to the final pathology
report
Non-severe acute cholecystitis
group (N = 179)
Severe acute cholecystitis
group (N = 116)
p
Gender [N (%)] 0.006
Male 74 (41.3) 67 (57.8)
Female 105 (58.7) 49 (42.2)
Age (years) 61 (43–77) 72 (64–80) < 0.001
Diabetes [N (%)] 15 (8.4) 26 (22.4) 0.001




164 (91.6) 105 (90.5) 0.834
Murphy’s sign [N (%)] 97 (54.2) 64 (55.7) 0.812
Pre-operative systemic signs of
inflammation
Temperature ≥ 38 °C [N (%)] 10 (5.6) 22 (19.0) < 0.001
Pre-operative total WBC count
(×103/μl)
9.3 (7.5–12.4) 14.4 (11.6–17.5) < 0.001
Pre-operative neutrophils count
(×103/μl)
6.5 (4.9–9.9) 11.6 (9.0–15.0) < 0.001
Pre-operative CRP level
(mg/dl)
1.2 (0.5–5.0) 13.7 (2.3–23.7) < 0.001
Pre-operative abdominal
ultrasound
Thickening of the gallbladder
wall [N (%)]
102 (57.0) 87 (75.0) 0.002
Pericholecystic fluid [N (%)] 22 (12.3) 30 (25.9) 0.005
Gallbladder enlargement
[N (%)]
126 (70.4) 91 (78.4) 0.138
Gallbladder stones [N (%)] 163 (91.1) 104 (89.7) 0.689
WBC white blood cell, CRP C-reactive protein
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CI 3.050–10.130), presence of US thickening of the gallblad-
der wall (OR 2.109; 95% CI 1.097–4.053), age as a continu-
ous variable, and CRP level ≥ 9.9 mg/dl were significantly
associated with severe acute cholecystitis in the final patholo-
gy report. Furthermore, a significant interaction between the
effect of age and CRP level was found; thus, the ORs for CRP
level were not constant over the age value, and the ORs for
several increments of age were influenced by the CRP level
(Tables 4 and 5). Table 4 shows the estimated ORs for CRP ≥
9.9 mg/dl versus CRP < 9.9 mg/dl with a higher OR for young
patients and lower OR for old patients. As shown in Table 5,
for CRP < 9.9 mg/dl, the ORs for age increments are increas-
ing and significant, while for CRP ≥9.9 mg/dl, the ORs are
decreasing and not significant. The presence of this significant
statistical interaction has important implications since the re-
lationship between each of the interacting covariates (age and
CRP) and the risk of having a severe acute cholecystitis de-
pends on the value of the other interacting predictor (i.e., it is
not simply additive).
Summarizing the estimated logit is
g^ xð Þ ¼ −5:02489þ 6:435956 CRP þ 1:71541
WBC þ 0:040997 Ageþ 0:746232
 Thick−0:06786 CRP  Ageð Þ
where all the estimated coefficients resulted significant
(p < 0.05).
A nomogram was employed and it is shown in Fig. 2a. The
model likelihood ratio (LR), which assesses the overall signif-
icance of the model, is 125.00 (p < 0.0001) and the goodness
of fit test 19 is z = 0.086 (p = 0.932). Therefore, there is no
evidence of lack of fit.24,25 The model calibration shows a
high agreement between predicted probabilities and observed
frequencies of the event of interest (Fig. 2b). The ROC curve
for the fitted model shows an AUC = 0.857 (95% CI 0.813–
0.900) which indicates that the model has a good discrimina-
tion ability.
The overall predictive accuracy of the models applied to
the validation cohort, as measured by the area under ROC
curve, was 0.6719 (95% CI 0.5508–0.7931).
Nomogram Application
In a patient with a suspected acute cholecystitis, a point value
is assigned for each variable in the nomogram using the first
line, and then each point value is summed to obtain both a
total point value and the predicted probability of having a
severe acute cholecystitis (Fig. 2a). Due to the interaction
between age and CRP, the point value for age in patients with
CRP < 9.9 mg/dl must be calculated with the second line of
the nomogram, instead for patients with CRP ≥ 9.9 mg/dl the
third line must be used. Consequently, in patients with CRP ≥
9.9 mg/dl, an age increasing is related to a decreasing in the
point value assigned.
Four risk classes were identified on the basis of the estimat-
ed probability of having a severe acute cholecystitis [i.e., low
risk (0–0.1); intermediate risk (0.1–0.4); high risk (0.4–0.7);
very high risk (0.7–1)] which correspond to four ranges of
nomogram total points [i.e., (0–42); (43–73); (74–95); (≥
96)]. Furthermore, a cutoff analysis found that the cutoff which
maximizes both sensitivity and specificity in predicting severe
acute cholecystitis corresponded to a nomogram total point of
74 [sensitivity = 78.5%, specificity = 78.2%, accuracy =
78.3%, positive predictive value (PPV) = 70%, negative pre-
dictive value (NPV) = 84.8%]. As shown in Fig. 3, the rate of
Fig. 1 ROC curves in the derivation cohort showed white blood cell (WBC) count (a) and C-reactive protein (CRP) level (b), as a single predictor of
severe acute cholecystitis
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a severe acute cholecystitis in the derivation and validation
cohorts increases significantly according to the risk score
stratification (Cochran-Armitage trending test for derivation
cohort p < 0.0001, and for validation cohort p < 0.02).
Discussion
The identification of patients with severe acute cholecystitis
(i.e., gangrenous and phlegmonous) may help the acute care
surgeon to guarantee the proper timing for the surgical opera-
tion during the first evaluation in the emergency setting, and to
hasten the treatment in some patients. Previous studies identi-
fied some predictive factors of acute gangrenous cholecystitis
such asmale gender, age older than 45 or 50 years, presence of
diabetes and cardiovascular disease, fever, elevation of WBC
count, US thickening of the gallbladder wall, US gallbladder
enlargement, and US pericholecystic fluid.3,7,9–15 However,
the results of risk analyses are expressed as ORs, which makes
it difficult to apply in the clinical practice of the acute care
surgeon. Furthermore, during the clinical evaluation, it is quite
difficult to apply the predictive equation for the diagnosis of
acute gangrenous cholecystitis proposed by Nguyen et al.11
As reported by Borzellino et al., the severe form of acute
cholecystitis should include both gangrenous and
phlegmonous cholecystitis, due to their severe clinical
course.3 Nowadays, there are no studies that have developed
an easy graphical tool to identify patients with a severe acute
cholecystitis. In the current study, age as a continuous
Table 4 Estimated odds ratios and 95% confidence intervals for CRP ≥
9.9 mg/dl versus CRP < 9.9 mg/dl for several values of age
Age (years) Estimated odds ratio 95% confidence interval
30 81.46467 9.1362 726.3946
35 58.02487 8.2533 407.9453
40 41.32939 7.4301 229.8928
45 29.4377 6.6552 130.2116
50 20.9676 5.9146 74.3313
55 14.9346 5.1899 42.9764
60 10.63747 4.4550 25.3996
65 7.576755 3.6773 15.6113
70 5.396698 2.8393 10.2575
75 3.843908 1.9997 7.3890
80 2.737902 1.2899 5.8114
85 1.950126 0.7839 4.8514
Table 3 Association between
baseline characteristics, local and
systemic signs of inflammation,
and abdominal ultrasound
findings and severe acute
cholecystitis according to
univariate logistic regression




Odds ratio 95% confidence interval p
Patients’ characteristics
Gender (ref, female)
Male 1.940 1.208–3.115 0.006
Age (per year) 1.044 1.027–1.062 < 0.001
Diabetes (ref, absence)
Presence 3.159 1.591–6.269 0.001
Local signs of inflammation
Murphy’s sign (ref, absence)
Presence 1.061 0.662–1.699 0.806
RUQ mass/pain/tenderness (ref, absence)
Presence 0.873 0.386–1.974 0.744
Systemic signs of inflammation
Temperature (ref, < 38 °C)
≥ 38 °C 3.956 1.797–8.701 < 0.001
Pre-operative total WBC count (ref, < 12.4 × 103/μl)
≥ 12.4 × 103/μl 7.490 4.426–12.674 < 0.001
Pre-operative CRP level (ref, < 9.9 mg/dl)
≥ 9.9 mg/dl 9.043 5.155–15.866 < 0.001
Abdominal ultrasound findings characteristic
of acute cholecystitis
Thickening of the gallbladder wall (ref, absence)
Presence 2.265 1.355–3.786 0.002
Pericholecystic fluid (ref, absence)
Presence 2.489 1.353–4.580 0.003
Gallbladder enlargement (ref, absence)
Presence 1.531 0.886–2.645 0.127
Gallbladder stones (ref, absence)
Presence 0.851 0.387–1.870 0.688
WBC white blood cell, CRP C-reactive protein
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Fig. 2 Nomogram to predict the
probability of severe acute
cholecystitis (a) and the
calibration plot (b)
Table 5 Estimated odds ratios
and 95% confidence intervals for
several increments of age
according to CRP ≥ 9.9 mg/dl and
CRP < 9.9 mg/dl
CRP < 9.9 mg/dl CRP ≥ 9.9 mg/dl
Increments of age (years) Odds ratio 95% confidence interval Odds ratio 95% confidence interval
5 1.04185 1.01727–1.06703 0.97349 0.93177–1.01709
10 1.22751 1.08937–1.38316 0.87432 0.70233–1.08842
15 1.50677 1.18672–1.91314 0.76443 0.49326–1.18466
20 1.84957 1.29277–2.64618 0.66835 0.34643–1.28942
25 2.27036 1.40830–3.66010 0.58435 0.24331–1.40343
30 3.42091 1.67126–7.00227 0.44669 0.12001–1.66259
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variable, WBC count ≥ 12.4 × 103/μl, CRP level ≥ 9.9 mg/dl,
and presence of thickening of the gallbladder wall in the ab-
dominal US evaluation were significantly associated with se-
vere acute cholecystitis (i.e., gangrenous and phlegmonous) at
final pathology report. Furthermore, it has been shown that the
levels of CRP increase with age,26 and this interaction may be
supported by the fact that younger age reflects fewer chronic
conditions and better physical health, with a consequent lower
chronic systemic inflammation. In this study, an interaction
between age and CRP level has been found; thus, a CRP
level ≥ 9.9 mg/dl in young patients reflects a higher risk of
severe acute inflammation of the gallbladder compared to
older patients (Table 4). Based on these findings and using
four information readily available during the evaluation of
the patients, we have developed an easy graphical tool (i.e.,
nomogram—Fig. 2a) with a good discrimination ability (AUC
= 0.857) to help the acute care surgeon to identify patients
with severe acute cholecystitis who might be addressed to an
earlier surgical operation, supported by the fact that gangre-
nous and phlegmonous cholecystitis were considered more
life-threatening conditions than edematous cholecystitis.3 It
is clear that, in patients with acute gangrenous and
phlegmonous cholecystitis, the best schedule for such a diffi-
cult cholecystectomy is the first case in the morning when the
team is fresh and ready to deal a challenging operation; how-
ever, these two pathologies have the potential to evolve to
more serious conditions with a systemic organ dysfunction if
surgery is delayed. Thus, according to the nomogram evalua-
tion, patients with a total point ≥ 74 (sensitivity = 78.5%, spec-
ificity = 78.2%, accuracy = 78.3%, PPV = 70%, NPV =
84.8%) are classified by the model with a high risk of severe
acute cholecystitis and they may be considered for surgical
operation to reduce the possible risk of progression of the
disease process such as intraluminal hemorrhage, perforation,
abscess formation, septic shock, and multiple organ
dysfunction. On the other hand, in patients with a total point
≤ 73 (low or intermediate risk of severe acute cholecystitis),
the surgical operation may be deferred or avoided by giving
priority to patients with more severe pathologies.
Limitations of the Study
This study has some limitations which have to be pointed out.
Firstly, this is a retrospective study in which 123 patients were
excluded because the CRP or the abdominal US were not
performed during the first evaluation in the emergency or
medical departments, and a selection bias may occur.
However, in spite of the retrospective nature of the study, the
data collected from the hospital electronic medical records of
the remaining 393 patients were incorporated in the electronic
records prospectively during the hospital stay of the patients,
and this supports the accuracy of the data collection. Secondly,
in the validation cohort, there are a low number of patients
with severe acute cholecystitis that may influence the predic-
tive accuracy of the model applied to the validation cohort of
patients. However, the Cochran-Armitage trending test con-
firms the significant increase in the rate of severe acute cho-
lecystitis according to the risk score stratification in both the
derivation and validation cohorts, and this supports the poten-
tial role of the nomogram in the clinical practice. Thirdly, this
nomogram seems a useful graphical tool to identify patients
with severe acute cholecystitis; however due to the study de-
sign without control group, it is not possible to evaluate the
external validity of the nomogram and its influence on the
timing of surgical operation and postoperative outcomes.
Thus, this nomogram will be validated in a prospective study
with the aims to compare the nomogram risk score stratifica-
tion with the pathological diagnosis of severe acute cholecys-
titis, to improve the risk score stratification, to evaluate its



























Nomogram Total Point (Risk Class)
Severe acute cholecystitis - Derivation cohort Severe acute cholecystitis - Validation cohortFig. 3 Observed percentage of
patients with severe acute
cholecystitis according to the
nomogram total point and the risk
score stratification in the
derivation and validation cohorts
(Cochran-Armitage trending test
for derivation cohort p < 0.0001,
and for validation cohort p < 0.02)
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approach (i.e., laparoscopy or open cholecystectomy), conver-
sion rate, complications and mortality, and to identify the best
nomogram total point cutoff useful to prioritize patients for
emergency surgical operations.
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